Results 151 to 160 of about 1,414 (186)
Some of the next articles are maybe not open access.
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization in Nursing Women
Breastfeeding Medicine, 2021Purpose: To report the clinical course and vascular endothelial growth factor (VEGF) levels in breast milk among three nursing women diagnosed with idiopathic choroidal neovascularization (CNV) before and after intravitreal injection of conbercept. Methods: This was an observational case series.
Zheyi Shao +8 more
openaire +2 more sources
Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept
Current Eye Research, 2020Purpose: To provide a detailed review on the therapeutic efficacy of conbercept for the management of ocular vasculopathies. Methods: A comprehensive literature search of various electronic databases was performed. Results: Ocular vasculopathy is one of the major causes of visual impairment and blindness which includes a range of disorders.
Huan Liu +5 more
openaire +2 more sources
Journal of Diabetes ResearchConclusions: Intravitreal conbercept injection presents dual effects of antiangiogenesis and anti-inflammation and can be served as an adjuvant treatment to vitrectomy for PDR ...
Weiqi Chen, Zijing Huang
exaly +2 more sources
Efficacy of intravitreal conbercept injection in the treatment of retinopathy of prematurity
British Journal of Ophthalmology, 2018BackgroundTo evaluate the safety and efficacy of intravitreal conbercept (IVC) injection in the treatment of retinopathy of prematurity (ROP).MethodsPatients with ROP who underwent IVC injection in Zhujiang Hospital from June 2015 to July 2016 were studied retrospectively. The primary outcome was defined as the regression of plus disease. The secondary
Yichen, Bai +6 more
openaire +2 more sources
One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema
Current Eye Research, 2017To evaluate the therapeutic efficacy of conbercept for the treatment of diabetic macular edema (DME) with different baseline visual acuity.This is a retrospective, comparative study. A total of 107 eyes of 107 patients were included. According to the levels of baseline best corrected visual acuity (BCVA) and therapeutic regimen, the DME patients were ...
Fengjiao, Li +6 more
openaire +2 more sources
SHORT-TERM EFFICACY OF CONBERCEPT AND RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
Retina, 2019Purpose: To compare the 6-month efficacy of the intravitreal injection of conbercept or ranibizumab for patients with polypoidal choroidal vasculopathy (PCV). Methods: This is a retrospective case–control study involved 79 PCV eyes of 77 patients.
Zhen, Huang +6 more
openaire +2 more sources
EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY
Retina, 2016To evaluate the efficacy of different doses of conbercept in patients with polypoidal choroidal vasculopathy in the AURORA study.Retrospective subgroup analyses of 12-month data from the AURORA study. Fifty-three patients (32 in 0.5-mg group and 21 in 2.0-mg group) diagnosed with polypoidal choroidal vasculopathy in AURORA study were retrospectively ...
Jinfeng, Qu +4 more
openaire +2 more sources
VITRECTOMY WITH SUBRETINAL TENECTEPLASE AND INTRAVITREAL CONBERCEPT FOR SUBMACULAR HEMORRHAGE
RetinaPurpose: To introduce a vitrectomy technique for the submacular hemorrhage (SMH) combined with subretinal tenecteplase injection, intravitreal conbercept administration, perfluoropropane gas tamponade, and to evaluate its efficacy and safety. Methods:
Mingwei Cui, Xiaomei Zhen, Shancheng Si
openaire +2 more sources